Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Tecan Group AG is a Swiss company specializing in the development, production, and distribution of laboratory instruments and automated workflow solutions for life sciences, biopharmaceuticals, forensics, clinical diagnostics, and medical technology. Founded in 1980 by four engineers in Hombrechtikon, it has grown into a global leader with over 3,500 employees, production and R&D sites across North America, Europe, and Asia-Pacific, and a sales network in 52 countries. Operating through Life Sciences Business and Partnering Business segments, Tecan Group AG offers liquid handling and automation systems, microplate readers and washers, software, consumables, NGS reagents, immunoassays, antibodies, and end-to-end solutions like Tecan Labwerx. As an OEM provider, it delivers customized components such as Cavro pumps, Synergence systems, and PARAMIT contract manufacturing services, supporting pharmaceutical firms, biotech companies, universities, diagnostic labs, and clinics. Headquartered in Männedorf, the company drives innovation in laboratory automation, enabling scalable healthcare advancements worldwide through strategic acquisitions and product launches like the Fluent platform and Veya workstation.
Operating margin is thin at 5.44%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue declined 5.5% YoY. Margins deteriorated 2.6pp alongside, both lines moving the wrong way.
Free cash flow declined 13% versus the prior year, cash generation momentum has weakened.
Profitability & Returns
Revenue (TTM)
CHF 882M
▼ -5.5% YoY
Net Income (TTM)
-CHF 111M
▼ -263.5% YoY
Op. Margin
5.44%
▼ -2.6pp YoY
ROIC
2.43%
▼ -1.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
CHF 103M
▼ -12.9% YoY
Op. Cash Flow (TTM)
CHF 118M
▼ -11.6% YoY
Net Debt
-CHF 93M
Net Cash Position
Cash & Equiv.
CHF 311M
3Y CAGR: -8.3%
3Y CAGR: +3.7%
Continue Research